Corosolic acid stimulates osteoblast differentiation by activating transcription factors and MAP kinases

Phytotherapy Research

Volumn 23, Issue 12, 2009, Pages 1754-1758

  Shim, Ki Shuk ^a   Lee, Su Ui ^a,b   Ryu, Shi Yong ^a   Min, Yong Ki ^a   Kim, Seong Hwan ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Corosolic acid; MAP kinase; Osteoblast differentiation; Transcription factor

Indexed keywords

COROSOLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; URSOLIC ACID DERIVATIVE;

ANIMAL CELL; ARTICLE; BANABA; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; LAGERSTROEMIA SPECIOSA; MEDICINAL PLANT; MINERALIZATION; MOUSE; NONHUMAN; OSTEOBLAST;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; LAGERSTROEMIA; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; OSTEOBLASTS; TRANSCRIPTION FACTORS; TRITERPENES;

LAGERSTROEMIA SPECIOSA;

EID: 73449108073     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2843     Document Type: Article

References (27)

1. Akhouayri O, St-Arnaud R. 2007. Differential mechanisms of transcriptional regulation of the mouse osteocalcin gene by Jun family members. Calcif Tissue Int 80: 123-131.
2. Boise LH, Petryniak B, Mao X et al. 1993. The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol Cell Biol 13: 1911-1919.
3. Eferl R, Hoebertz A, Schilling AF et al. 2004. The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J 23: 2789-2799.
4. Harada S, Rodan GA. 2003. Control of osteoblast function and regulation of bone mass. Nature 423: 349-355.
5. Hipskind RA, Bilbe G. 1998. MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 3: d804-d816.
6. Ikeda Y, Murakami A, Ohigashi H. 2005. Corosolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem Pharmacol 70: 1497-1505.
7. Jeong JG, Kim YS, Min YK, Kim SH. 2007. Low concentration of 3-carene stimulates the differentiation of mouse osteoblastic MC3T3-E1 subclone 4 cells. Phytother Res 22: 18 -22.
8. Kim YK, Yoon SK, Ryu SY. 2000. Cytotoxic triterpenes from stem bark of Physocarpus intermedius. Plant Med 66: 485-486.
9. Koga T, Matsui Y, Asagiri M et al. 2005. NFAT and Osterix cooperatively regulate bone formation. Nat Med 11: 880-885.
10. Lai CF, Chaudhary L, Fausto A et al. 2001. Erk is essential for growth, differentiation, integrin expression, and cell function in human osteoblastic cells. J Biol Chem 276: 14443-14450.
11. Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LJ. 2004. Modeling the interaction between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229: 293-309.
12. -ΔΔCT method. Methods 25: 402-408.
13. Lu X, Gilbert L, He X, Rubin J, Nanes MS. 2006. Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem 281: 6297-6306.
14. Miura T, Ueda N, Yamada K et al. 2006. Antidiabetic effects of corosolic acid in KK-Ay diabetic mice. Biol Pharm Bull 29: 585-587.
15. Rodan GA, Martin TJ. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514.
16. Rozen S, Skaletsky HJ. 2000. Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S, Misener S (eds). Humana Press: Totowa, 365-386.
17. Shi L, Zhang W, Zhou YY et al. 2008. Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol 584: 21-29.
18. Suzuki A, Guicheux J, Palmer G et al. 2002. Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone 30: 91-98.
19. Teitelbaum SL. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508.
20. Wagner EF. 2002. Functions of AP1 (Fos/Jun) in bone development. Ann Rheum Dis 61: ii40-ii42.
21. Wang D, Christensen K, Chawla K, Xiao G, Krebsbach PH, Franceschi RT. 1999. Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential. J Bone Miner Res 14: 893-903.
22. Winslow MM, Pan M, Starbuck M et al. 2006. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10: 771-782.
23. Yamaguchi Y, Yamada K, Yoshikawa N, Nakamura K, Haginaka J, Kunitomo M. 2006. Corosolic acid prevents oxidative stress, inflammation and hypertension in SHR/NDmcr-cp rats, a model of metabolic syndrome. Life Sci 79: 2474-2479.
24. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. 1995. Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem 270: 31315-31320.
25. Yoon HK, Baylink DJ, Lau KH. 2000. Protein tyrosine kinase inhibitors block the stimulatory actions of phosphotyrosine phosphatase inhibitors to increase cell proliferation, alkaline phosphatase activity, and collagen synthesis in normal human bone cells. Am J Nephrol 20: 153-162.
26. You HJ, Choi CY, Kim JY, Park SJ, Hahm KS, Jeong HG. 2001. Corosolic acid enhances nitric oxide and tumor necrosis factor-alpha production via nuclear factor-kappaB activation in the resting macrophages. FEBS Lett 509: 156-160.
27. Zong W, Zhao G. 2007. Corosolic acid isolation from the leaves of Eriobotrta japonica showing the effects on carbohydrate metabolism and differentiation of 3T3-L1 adipocytes. Asia Pac J Clin Nutr 16: 346-352.